Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00077324 · ClinicalTrials.gov registry record
Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT00077324 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,000 participants.
The verdict
NCT00077324 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
RATIONALE: Evaluating specific proteins in the blood may be an effective and noninvasive procedure to help doctors determine if a patient has early non-small cell lung cancer. PURPOSE: This clinical trial is studying proteomic profiling to see how well it works in diagnosing non-small cell lung cancer in patients who are undergoing resection for suspicious (abnormal) stage I lung lesions.
Interventions
- PROCEDURE biopsy
- PROCEDURE surgery
- GENETIC proteomic profiling
- OTHER surface-enhanced laser desorption/ionization-time of flight mass spectrometry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2004-02 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00077324
The ClinicalTrials.gov registry entry for NCT00077324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which biopsy is the first listed.
NCT00077324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00077324 about?
NCT00077324 is a clinical study titled "Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions". RATIONALE: Evaluating specific proteins in the blood may be an effective and noninvasive procedure to help doctors determine if a patient has early non-small cell lung cancer. PURPOSE: This clinical trial is studying proteomic profiling to see how well it works in diagnosing non-small cell lung can...
What is the current status of trial NCT00077324?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2004-02. Estimated completion is 2011-11.
What interventions are being tested in trial NCT00077324?
The interventions under investigation include: biopsy (PROCEDURE), surgery (PROCEDURE), proteomic profiling (GENETIC), surface-enhanced laser desorption/ionization-time of flight mass spectrometry (OTHER).
Who is sponsoring clinical trial NCT00077324?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.